Composite Magnetic Sorbents Based on Iron Oxides in Different Polymer Matrices: Comparison and Application for Removal of Strontium.

Introduction of magnetic nanoparticles into composite sorbents based on polymer matrices has received great attention due to the possibility of using cheap iron oxides and removing spent sorbents by means of magnetic separation. In the present paper, we discuss the problem of creating magnetic sorbents using two types of matrices as host materials: synthetic cation exchange resin and natural aminopolysaccharide chitosan. The possibilities of applying matrices for the in situ formation of oxide phases of a specified composition with the required content of an inorganic component in a composite material were estimated.

Synthesis and Sorption Properties towards Sr-90 of Composite Sorbents Based on Magnetite and Hematite.

The article describes the synthesis of composite sorbents by immobilizing iron oxide in a polymer matrix with subsequent hydrothermal treatment at a temperature of 175 °C. The sorbents based on magnetite and hematite were synthesized, their magnetic properties and phase composition were evaluated, and the iron content was determined. Sorption characteristics of the composites towards microconcentrations of Sr-90 radionuclide in solutions with different mineralization and pH were investigated.

From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis.

CD28 superagonists (CD28SA) are CD28-specific monoclonal antibodies which are able to activate T-cells without overt TCR engagement. In rodents, CD28SA efficiently activate regulatory T-cells and are therapeutically effective in multiple models of autoimmunity, inflammation and transplantation. However, a phase I study of the human CD28SA TGN1412 in 2006 resulted in a life-threatening cytokine storm.

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens.

Peripheral blood mononuclear cells (PBMCs) are the only source of human lymphoid cells routinely available for immunomonitoring of T-cell responses to microbial and tumor-associated antigens. However, previous work in mice and humans had indicated that CD4 T cells transiently lose antigen sensitivity when cellular contacts are lost (eg, by entering the circulation). Using the simple and robust protocol for resetting T cells to original reactivity (RESTORE; ie, preculturing PBMCs for 2 days at a high cell density before initiation of antigenic stimulation), we show that CD8 T-cell responses to viral and tumor-associated antigens are greatly underestimated in blood, and sometimes even remain undetected, if conventional, unprocessed PBMC cultures are used.

Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response.

Following inconspicuous preclinical testing, the superagonistic anti-CD28 mAb TGN1412 was applied to six study participants who all developed a devastating cytokine storm. We verified that TGN1412 treatment of fresh PBMCs induced only moderate responses, whereas restoration of tissue-like conditions by high-density preculture (HDC) allowed vigorous cytokine production. TGN1412 treatment of T cells isolated from HDC-PBMCs induced moderate cytokine responses, which upon additional anti-IgG crosslinking were significantly boosted.